Avalon GloboCare Corp. Common Stock
ALBTAvalon GloboCare Corp. is a biotechnology company focused on developing and commercializing cell-based therapies and diagnostic products. The company explores innovative solutions in regenerative medicine, immunotherapy, and personalized healthcare, aiming to advance treatment options in various medical fields.
Company News
A class action lawsuit has been filed against Concorde International Group, Ltd. (NASDAQ: CIGL) alleging securities fraud. The complaint claims defendants made materially false statements and failed to disclose a fraudulent stock promotion scheme involving social media misinformation, coordinated share dumping by insiders using offshore accounts,...
U.S. stock futures fell sharply on Monday following geopolitical tensions with Iran, with the S&P 500, Dow Jones, and Nasdaq 100 all declining. The death of Iran's Supreme Leader and potential continuation of military strikes for weeks dampened market sentiment. Key movers included AMTD Digital surging 20% on strong revenue results, Aardvark Ther...
Avalon GloboCare Corp. (NASDAQ: ALBT) closed a private placement raising $3.25 million upfront with up to $6.5 million in potential proceeds from warrant exercises. The company plans to use net proceeds for debt repayment and working capital. The offering included 6.37 million common shares and warrants priced at $0.51 per share.
Avalon GloboCare Corp. (NASDAQ: ALBT) announced a private placement of 6.37 million shares at $0.51 per share, generating $3.25 million in upfront proceeds with potential additional $6.5 million from warrant exercises. The company plans to use net proceeds for debt repayment and working capital. H.C. Wainwright & Co. is the exclusive placement ag...
Avalon GloboCare has acquired RPM Interactive, a generative AI software company, in an all-stock transaction valued at $19.5 million. The acquisition creates a new subsidiary, Avalon Quantum AI, and is expected to help resolve Nasdaq's minimum stockholders' equity requirements.
